Prodrugs of fumarates and their use in treating various diseases
Tarek A. Zeidan, Lexington, MA (US); Scott Duncan, Bedford, MA (US); Christopher P. Hencken, Boston, MA (US); Thomas Andrew Wynn, Lexington, MA (US); and Carlos N. Sanrame, Lexington, MA (US)
Assigned to Alkermes Pharma Ireland Limited, Dublin (IE)
Filed by Alkermes Pharma Ireland Limited, Dublin (IE)
Filed on May 9, 2023, as Appl. No. 18/144,890.
Application 18/144,890 is a continuation of application No. 17/365,199, filed on Jul. 1, 2021, granted, now 11,679,092.
Application 17/365,199 is a continuation of application No. 16/790,849, filed on Feb. 14, 2020, granted, now 11,083,703, issued on Aug. 10, 2021.
Application 16/790,849 is a continuation of application No. 16/524,498, filed on Jul. 29, 2019, granted, now 10,596,140, issued on Mar. 24, 2020.
Application 16/524,498 is a continuation of application No. 16/145,703, filed on Sep. 28, 2018, granted, now 10,406,133, issued on Sep. 10, 2019.
Application 16/145,703 is a continuation of application No. 15/704,219, filed on Sep. 14, 2017, granted, now 10,117,846, issued on Nov. 6, 2018.
Application 15/704,219 is a continuation of application No. 15/295,370, filed on Oct. 17, 2016, granted, now 9,775,823, issued on Oct. 3, 2017.
Application 15/295,370 is a continuation of application No. 14/212,745, filed on Mar. 14, 2014, granted, now 9,505,776, issued on Nov. 29, 2016.
Claims priority of provisional application 61/934,365, filed on Jan. 31, 2014.
Claims priority of provisional application 61/782,445, filed on Mar. 14, 2013.
Prior Publication US 2024/0024275 A1, Jan. 25, 2024
